These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7781803)

  • 41. Rabs and cancer cell motility.
    Tang BL; Ng EL
    Cell Motil Cytoskeleton; 2009 Jul; 66(7):365-70. PubMed ID: 19418559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of metastatic potential of aspirated cells from the Dunning R-3327 prostatic adenocarcinoma model.
    Doyle GM; Mohler JL
    J Urol; 1992 Mar; 147(3):756-9. PubMed ID: 1538478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis.
    Brown GT; Murray GI
    J Pathol; 2015 Nov; 237(3):273-81. PubMed ID: 26174849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Drebrin in Cancer Cell Invasion.
    Dart AE; Gordon-Weeks PR
    Adv Exp Med Biol; 2017; 1006():375-389. PubMed ID: 28865033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumour invasion and metastasis: therapeutic implications?
    Mareel MM; Bracke ME; Boghaert ER
    Radiother Oncol; 1986 Jun; 6(2):135-42. PubMed ID: 3526422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasion and metastasis: biology and clinical potential.
    Kohn EC
    Pharmacol Ther; 1991 Nov; 52(2):235-44. PubMed ID: 1818338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-cell motility and invasion within tumors determined by applying computer simulation to histologic patterns.
    Smolle J; Grimstad IA
    Int J Cancer; 1992 Jan; 50(2):331-5. PubMed ID: 1730529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of cancer cell motility in invasion.
    Sträuli P; Haemmerli G
    Cancer Metastasis Rev; 1984; 3(2):127-41. PubMed ID: 6567481
    [No Abstract]   [Full Text] [Related]  

  • 50. Dynamics of 3D carcinoma cell invasion into aligned collagen.
    Ray A; Morford RK; Ghaderi N; Odde DJ; Provenzano PP
    Integr Biol (Camb); 2018 Feb; 10(2):100-112. PubMed ID: 29340409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.
    Entschladen F; Drell TL; Lang K; Joseph J; Zaenker KS
    Lancet Oncol; 2004 Apr; 5(4):254-8. PubMed ID: 15050959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase.
    Wennström S; Siegbahn A; Yokote K; Arvidsson AK; Heldin CH; Mori S; Claesson-Welsh L
    Oncogene; 1994 Feb; 9(2):651-60. PubMed ID: 8290276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis.
    Lester BR; McCarthy JB
    Cancer Metastasis Rev; 1992 Mar; 11(1):31-44. PubMed ID: 1511495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rho family proteins in cell adhesion and cell migration.
    Evers EE; Zondag GC; Malliri A; Price LS; ten Klooster JP; van der Kammen RA; Collard JG
    Eur J Cancer; 2000 Jun; 36(10):1269-74. PubMed ID: 10882865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis.
    Silva P; Mendoza P; Rivas S; Díaz J; Moraga C; Quest AF; Torres VA
    Oncotarget; 2016 May; 7(20):29548-62. PubMed ID: 27121131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression.
    Enderling H; Hlatky L; Hahnfeldt P
    Math Med Biol; 2012 Mar; 29(1):21-9. PubMed ID: 20929852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model.
    Doyle GM; Sharief Y; Mohler JL
    J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer dissemination: a consequence of limited carrying capacity?
    Deisboeck TS; Wang Z
    Med Hypotheses; 2007; 69(1):173-7. PubMed ID: 17196762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis.
    Sakurai Y; Sawada T; Chung YS; Funae Y; Sowa M
    Clin Exp Metastasis; 1997 May; 15(3):307-17. PubMed ID: 9174130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor implantation and invasion at metastatic sites.
    Nicolson GL; Poste G
    Int Rev Exp Pathol; 1983; 25():77-181. PubMed ID: 6365823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.